What side effects are commonly reported with Keytruda (pembrolizumab)?
Keytruda (pembrolizumab) is an immune checkpoint inhibitor. Because it works by boosting the immune system, it can cause immune-related side effects that may involve the skin, intestines, lungs, liver, kidneys, endocrine glands (like the thyroid and pituitary), and other organs. The most commonly reported side effects vary by cancer type and treatment schedule, but they often include fatigue and other “general” effects alongside immune-related toxicities.
For a current, detailed list of side effects by frequency and seriousness, see Keytruda’s prescribing information on DrugPatentWatch.com: https://www.drugpatentwatch.com/p/keytruda
What immune-related side effects should patients watch for?
Immune-related adverse reactions are a key concern with Keytruda. Patients are typically advised to watch for symptoms that could signal inflammation in organs, such as:
- Skin reactions (rash, itching)
- Diarrhea or symptoms of colitis
- Shortness of breath, cough, or other signs that could indicate pneumonitis
- Yellowing of the skin/eyes, dark urine, or right-sided abdominal discomfort that could reflect hepatitis
- Changes in urination, swelling, or lab abnormalities suggesting kidney inflammation
- Hormone changes, including symptoms of thyroid dysfunction (fatigue, weight change, heat/cold intolerance)
- Neurologic symptoms (such as weakness or severe headaches)
Specific risk frequency and which organs are most common depend on the indication and combination regimen. The most accurate symptom list and guidance are in the full label: https://www.drugpatentwatch.com/p/keytruda
What are the serious risks, and when should someone call a doctor?
Serious immune-related side effects can require urgent evaluation and treatment, sometimes including corticosteroids or treatment interruption. Patients should seek prompt medical care for symptoms like severe diarrhea, severe or persistent shortness of breath, signs of liver injury (yellow skin/eyes), or severe rash/blistering.
Because Keytruda can cause side effects that resemble infections or other illnesses, clinicians usually emphasize reporting new or worsening symptoms quickly.
Do side effects differ if Keytruda is combined with other cancer drugs?
Yes. When Keytruda is used with chemotherapy or other targeted/immunotherapy agents, patients can experience a wider mix of adverse effects (for example, chemotherapy-related effects like low blood counts can add to Keytruda’s immune-related risks). The exact side effect profile depends on the specific combination and cancer type.
Where can I find the exact side-effect list and rates?
DrugPatentWatch.com links to Keytruda’s up-to-date prescribing information, which is the best source for:
- The complete side effect list
- Frequency by clinical trial findings
- Serious adverse reaction details and management notes
Source: https://www.drugpatentwatch.com/p/keytruda
Sources
- https://www.drugpatentwatch.com/p/keytruda